Dhara N. Amin

Tumor-Associated Endothelial Cells with Cytogenetic Abnormalities

Kyoko Hida, Yasuhiro Hida, Dhara N. Amin et al. · Cancer Research · 2004 · 462 citations · Full text

Medicine, Cell Biology, Oncology +11

Antibody targeting of E3 ubiquitin ligases for receptor degradation

Hadir Marei, Wen‐Ting K. Tsai, Yee-Seir Kee et al. · Nature · 2022 · 255 citations · Full text

Life Sciences, Biochemistry, Oncology +16

Tumor Endothelial Cells Express Epidermal Growth Factor Receptor (EGFR) but not ErbB3 and Are Responsive to EGF and to EGFR Kinase Inhibitors

Dhara N. Amin, Kyoko Hida, Diane R. Bielenberg et al. · Cancer Research · 2006 · 217 citations · Full text

Medicine, Cell Biology, Oncology +17

Resiliency and Vulnerability in the HER2-HER3 Tumorigenic Driver

Dhara N. Amin, Natalia Sergina, Deepika Ahuja et al. · Science Translational Medicine · 2010 · 185 citations · Full text

Medicine, Cancer Biology, Oncology +14

HER3 Comes of Age: New Insights into Its Functions and Role in Signaling, Tumor Biology, and Cancer Therapy

Marcia R. Campbell, Dhara N. Amin, Mark M. Moasser · Clinical Cancer Research · 2010 · 184 citations · Full text

Medicine, Cancer Biology, Oncology +12